admin

admin

CytoSorbents reports Q4 revenue growth via Investing.com

PRINCETON, NJ – CytoSorbents Corporation (NASDAQ: CTSO ), a medical device company specializing in hemodialysis with a market capitalization of $50.31 million, announced preliminary financial results for the fourth quarter and full year of 2024. According to InvestingPro data, the…